PCTL News ***
PCT LTD Issues Company Update and Signs Collaborative Agreement for Oil & Gas, and Cannabis Applications
https://www.newsfilecorp.com/release/50820
Little River, South Carolina--(Newsfile Corp. - December 16, 2019) - PCT LTD (OTC Pink PCTL), designer of the Annihilyzer® Infection Control System "Annihilyzer® System" a whole-room cleaning and disinfecting system for hospital and healthcare facilities, is pleased to release the following status update:
PCT LTD, through its operating company Paradigm Convergence Technologies Corporation (PCT Corp.), has launched the Annihilyzer® Infection control system, a revolutionary product line that reduces the likelihood of acquiring HAI's (Hospital Associated Infections) within hospitals in the United States and Europe. Our years of experience with the products we've researched, developed and are now successfully delivering to hospitals tells us that generating substantial revenue can coincide with delivering "green" solutions to our customers, utilizing responsible disinfectants that do not harm people or our environment. The antimicrobial products delivered by the Annihilyzer® System create fatal damage to the cell walls of unwanted, dangerous pathogens such as antibiotic-resistant bacteria, viruses, yeast and fungi.
PCT LTD's mandate to PCT Corp. continues to be to strategically, methodically and successfully enter and gain market share within three industries: healthcare, agriculture, and oil & gas. The company has recently been increasing earned income from the sale of services, disinfecting and sanitizing fluid, equipment, and/or non-essential intellectual property thereby reducing operating deficits. Addition growth and funding may also result in an increase in hiring to aid in sales and marketing in order to make faster gains towards achieving profitability.
Revenue generation is accelerating due to the gains made by PCT Corp.'s installations of Annihilyzer® Infection Control Systems, which are being deployed to hospitals through internal sales efforts in concert with distributors and/or manufacturer's representative(s). Ten (10) Annihilyzer® Infection Control Systems have been installed in seven (7) different hospitals, including one in the United Kingdom, and three (3) more are slated for installation within the next several weeks . Furthermore, most of these facilities are already in the long-term planning and budgeting process to expand their systems in the future. The initial analysis of the sales cycle shows a 6- to18-month sales cycle, including a 60-day trial installation and initial training, concurrent with hospital budgeting/contracting, and system expansion/training. The sales cycle begins when we (PCT staff and our distributor) first engage a strategic customer (hospital), but ultimately the sales process involves helping the environmental services department, infection control department, nursing department, CFO, and other various stakeholders understand how the system beneficially affects their workload, infection rates, employee morale and welfare, patient turnover, surgery center output, reimbursements, patient satisfaction, insurance, and other cost reductions. Typically, before committing to a multiyear agreement, the facility will want to conduct a 60-day trial installation to confirm the system truly has the potential to benefit their operations like it has at other facilities. To help off-set costs for the trial installation, PCT Corp. invoices a small, reasonable amount which, by putting just a little bit of "skin in the game", shows a sincere commitment from the facility to give it a "fair shake". After the trial period is over, we have not yet had to remove a system, although hospitals may require a little more time for creative budgeting or interim payment arrangements until they can execute a longer-term master service agreement (lease), This strategy is paying off for us as this proof of concept continues to show true viability and we will soon have a track record of demonstrated performance and effectiveness that will allow us to eliminate the need for trial periods with new customers.
PCT Corp. also sells equipment and fluid solutions to food processing customers, agricultural customers (The company continues research, reporting and registration data completion to the US EPA continues in this market.), and is making gains into selling equipment to oil & gas industry customers who are performing further research for the most effective manner to produce and use the fluid solutions. Most recently, PCT Corp. has executed a collaborative agreement with Advanced Environmental Solutions, Inc. "AES, Inc." of Meeker, Oklahoma. AES, Inc. purchased two (2) high-volume units of PCT Corp.'s equipment and is building out a 2,500 s.f. production facility as it develops its oil & gas and Cannabis applications.
We will work diligently to better communicate with the public. We understand the importance of communicating our progress in a timely and consistent manner and plan to provide additional business updates on a monthly basis . We also do not take lightly the fact that we are delinquent in filing our 2019 third quarter 10-Q. Our intent is to file our 10-Q as soon as practicable and we are discussing the best course of action in this regard . We encourage calling our investor relations team at Chesapeake Group to further discuss any information which is already public.
"We are achieving progress on multiple fronts, resulting in current and future revenue growth . The demand for our products remains strong. The current year has been one of building a strong foundation which we anticipate leveraging for accelerating growth moving forward," comments Gary Grieco, Chairman, PCT LTD.
About PCT LTD:
PCT LTD "PCTL" focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting and tracking technologies products. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, "PCTL" aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements." Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the continued positive results relating to the installation of PCT''s Annihilyzer® systems in hospitals; the results of any manufacturers' representative and/or license agreements, actual sales revenue to be derived from agreements, if any such contract is executed; PCT LTD's and its subsidiary's business prospects; PCT LTD's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCT LTD to execute its business plan or list its common stock on a national stock exchange; benefits of the Annihilyzer® Infection Control Systems, "high-volume" equipment or its suitability for market applications, Hydrolyte® generators and fluids; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCT LTD makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the United States Securities Exchange Commission. PCT LTD undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Contacts
Company:
Gary Grieco, President and Chairman of the Board
(843) 390-7900 Office
(843) 390-2347 Fax
www.para-con.com
www.pcthealth.com
www.survivalyte.com
Brokers and Analysts:
Chesapeake Group
+1-410-825-3930
info@chesapeakegp.com
PCT LTD Issues Company Update and Signs Collaborative Agreement for Oil & Gas, and Cannabis Applications
https://www.newsfilecorp.com/release/50820
Little River, South Carolina--(Newsfile Corp. - December 16, 2019) - PCT LTD (OTC Pink PCTL), designer of the Annihilyzer® Infection Control System "Annihilyzer® System" a whole-room cleaning and disinfecting system for hospital and healthcare facilities, is pleased to release the following status update:
PCT LTD, through its operating company Paradigm Convergence Technologies Corporation (PCT Corp.), has launched the Annihilyzer® Infection control system, a revolutionary product line that reduces the likelihood of acquiring HAI's (Hospital Associated Infections) within hospitals in the United States and Europe. Our years of experience with the products we've researched, developed and are now successfully delivering to hospitals tells us that generating substantial revenue can coincide with delivering "green" solutions to our customers, utilizing responsible disinfectants that do not harm people or our environment. The antimicrobial products delivered by the Annihilyzer® System create fatal damage to the cell walls of unwanted, dangerous pathogens such as antibiotic-resistant bacteria, viruses, yeast and fungi.
PCT LTD's mandate to PCT Corp. continues to be to strategically, methodically and successfully enter and gain market share within three industries: healthcare, agriculture, and oil & gas. The company has recently been increasing earned income from the sale of services, disinfecting and sanitizing fluid, equipment, and/or non-essential intellectual property thereby reducing operating deficits. Addition growth and funding may also result in an increase in hiring to aid in sales and marketing in order to make faster gains towards achieving profitability.
Revenue generation is accelerating due to the gains made by PCT Corp.'s installations of Annihilyzer® Infection Control Systems, which are being deployed to hospitals through internal sales efforts in concert with distributors and/or manufacturer's representative(s). Ten (10) Annihilyzer® Infection Control Systems have been installed in seven (7) different hospitals, including one in the United Kingdom, and three (3) more are slated for installation within the next several weeks . Furthermore, most of these facilities are already in the long-term planning and budgeting process to expand their systems in the future. The initial analysis of the sales cycle shows a 6- to18-month sales cycle, including a 60-day trial installation and initial training, concurrent with hospital budgeting/contracting, and system expansion/training. The sales cycle begins when we (PCT staff and our distributor) first engage a strategic customer (hospital), but ultimately the sales process involves helping the environmental services department, infection control department, nursing department, CFO, and other various stakeholders understand how the system beneficially affects their workload, infection rates, employee morale and welfare, patient turnover, surgery center output, reimbursements, patient satisfaction, insurance, and other cost reductions. Typically, before committing to a multiyear agreement, the facility will want to conduct a 60-day trial installation to confirm the system truly has the potential to benefit their operations like it has at other facilities. To help off-set costs for the trial installation, PCT Corp. invoices a small, reasonable amount which, by putting just a little bit of "skin in the game", shows a sincere commitment from the facility to give it a "fair shake". After the trial period is over, we have not yet had to remove a system, although hospitals may require a little more time for creative budgeting or interim payment arrangements until they can execute a longer-term master service agreement (lease), This strategy is paying off for us as this proof of concept continues to show true viability and we will soon have a track record of demonstrated performance and effectiveness that will allow us to eliminate the need for trial periods with new customers.
PCT Corp. also sells equipment and fluid solutions to food processing customers, agricultural customers (The company continues research, reporting and registration data completion to the US EPA continues in this market.), and is making gains into selling equipment to oil & gas industry customers who are performing further research for the most effective manner to produce and use the fluid solutions. Most recently, PCT Corp. has executed a collaborative agreement with Advanced Environmental Solutions, Inc. "AES, Inc." of Meeker, Oklahoma. AES, Inc. purchased two (2) high-volume units of PCT Corp.'s equipment and is building out a 2,500 s.f. production facility as it develops its oil & gas and Cannabis applications.
We will work diligently to better communicate with the public. We understand the importance of communicating our progress in a timely and consistent manner and plan to provide additional business updates on a monthly basis . We also do not take lightly the fact that we are delinquent in filing our 2019 third quarter 10-Q. Our intent is to file our 10-Q as soon as practicable and we are discussing the best course of action in this regard . We encourage calling our investor relations team at Chesapeake Group to further discuss any information which is already public.
"We are achieving progress on multiple fronts, resulting in current and future revenue growth . The demand for our products remains strong. The current year has been one of building a strong foundation which we anticipate leveraging for accelerating growth moving forward," comments Gary Grieco, Chairman, PCT LTD.
About PCT LTD:
PCT LTD "PCTL" focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting and tracking technologies products. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, "PCTL" aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.
Forward-Looking Statements
This press release contains "forward-looking statements" as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact and may be "forward-looking statements." Such statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Such statements involve risks and uncertainties, including but not limited to: any implied or perceived benefits resulting from the continued positive results relating to the installation of PCT''s Annihilyzer® systems in hospitals; the results of any manufacturers' representative and/or license agreements, actual sales revenue to be derived from agreements, if any such contract is executed; PCT LTD's and its subsidiary's business prospects; PCT LTD's ability to raise sufficient funds to satisfy its working capital requirements; the ability of PCT LTD to execute its business plan or list its common stock on a national stock exchange; benefits of the Annihilyzer® Infection Control Systems, "high-volume" equipment or its suitability for market applications, Hydrolyte® generators and fluids; any other effects resulting from the information disclosed above; risks and effects of legal and administrative proceedings and government regulation; future financial and operational results; competition; general economic conditions; and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements PCT LTD makes in this press release include market conditions and those set forth in reports or documents it files from time to time with the United States Securities Exchange Commission. PCT LTD undertakes no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Contacts
Company:
Gary Grieco, President and Chairman of the Board
(843) 390-7900 Office
(843) 390-2347 Fax
www.para-con.com
www.pcthealth.com
www.survivalyte.com
Brokers and Analysts:
Chesapeake Group
+1-410-825-3930
info@chesapeakegp.com
PCT Ltd. (PCTL) Stock Research Links
There are no guarantees in investing. No one should consider these pages or posts to be financial advice. Everyone has a responsibility to verify and thoroughly learn more than what is referenced or written here, and everyone must take responsibility for their own investing decisions.
